Skip to main content

Rejuveron Senescence Therapeutics

Prof. Manuel Serrano PhD

Co-founder & Scientific Advisor - Rejuveron Senescence Therapeutics

Manuel is Group Leader at IRB Barcelona. He is a renowned expert in senescence research and pioneered the concept that cellular senescence is critical to signal tissue damage and to elicit tissue regeneration.
Timothy Cash PhD

Co-founder & Chief Scientific Officer - Rejuveron Senescence Therapeutics

Tim has over 10 years of experience in the field of cellular damage and oncology working in the prestigious CNIO in Madrid. With previous experience in other longevity therapeutics ventures, he has a focus on the fields of aging and oncology.
Aksana Labokha PhD

Chief Executive Officer

Aksana brings 10+ years of experience in the life science and healthcare industry, including early-stage business development, company building, and venture. At Rejuveron she oversees investments, deal sourcing and contributes to strategic expansion of our portfolio companies.